LETARA 2.5mg contains Letrozole, a potent non-steroidal aromatase inhibitor. It is primarily prescribed for postmenopausal women diagnosed with hormone receptor-positive early or advanced breast cancer. It works by inhibiting the enzyme aromatase, which is responsible for the production of estrogen in fatty tissues. By lowering estrogen levels, Letara helps to slow or stop the growth of cancer cells that require estrogen to grow.

- Clinical Integrity: This product is fully registered with the Ministry of Health Malaysia (MAL12095086AZ), ensuring it meets the highest standards of safety and efficacy.

- Pro-Tip: Long-term use of Letrozole may affect bone mineral density. Consult your doctor about Calcium and Vitamin D supplementation to support bone health during treatment.

Key Ingredients:

- Active Ingredient: Each film-coated tablet contains Letrozole 2.5mg.

- Therapeutic Class: Aromatase Inhibitor / Antineoplastic agent.

Indications:

- Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.

- Extended adjuvant treatment of early breast cancer in postmenopausal women who have received prior standard tamoxifen therapy.

- First-line and second-line treatment in postmenopausal women with advanced breast cancer.